MALDI-TOF MS as a Label-Free Approach to Rapid Inhibitor Screening

被引:0
|
作者
Greis, Kenneth D. [1 ]
Zhou, Songtao [1 ]
Burt, Thomas M. [1 ]
Carr, Andrew N. [1 ]
Dolan, Elizabeth [1 ]
Easwaran, Vijayasurian [1 ]
Evdokimov, Artem [1 ]
Kawamoto, Richard [1 ]
Roesgen, Jeff [1 ]
Davis, Gregory F. [1 ]
机构
[1] Procter and Gamble Pharmaceuticals, Mason, OH, United States
关键词
Mass Spectrometry (MS) has been widely reported for measuring the conversion of substrates to products for enzyme assays. These measurements are typically performed by time-consuming LC-MS to eliminate buffer salts that interfere with electrospray ionization MS. However; matrix-assisted laser desorption ionization; time-of-flight MS (MALDI-TOF MS) offers a label-free and direct readout of substrate and product; a fast sampling rate; and is tolerant of many buffer salts; reagents; and compounds that are typically found in enzyme reaction mixtures. In this report; a demonstration of how MALDI-TOF MS can be used to directly measure ratios of substrates and products to produce IC50 curves for rapid enzyme assays and compound screening is provided. Typical reproducibility parameters were <7% RSD-a value comparable to ESI MS quantitative assays and well within the acceptable limits for screening assays. The speed of the MALDI readout is currently about 10 s per sample; thus allowing for over 7500 samples/day. From a simplicity standpoint; the enzymatic reaction mixtures are prepared by liquid handling robots; the reactions are stopped by addition of a 10 times volume of acidic matrix solution; and the samples are simultaneously transferred to MALDI target plate for analysis. Importantly; the ratios of substrate to product are of sufficient reproducibility to eliminate the need for internal standards and; thus; minimize the cost and increasing the speed of assay development. © 2006 American Society for Mass Spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Journal article (JA)
引用
收藏
页码:815 / 822
相关论文
共 50 条
  • [41] Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
    Lindgren, Asa
    Karami, Nahid
    Karlsson, Roger
    Ahren, Christina
    Welker, Martin
    Moore, Edward R. B.
    Stadler, Liselott Svensson
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (01) : 57 - 68
  • [42] Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
    Åsa Lindgren
    Nahid Karami
    Roger Karlsson
    Christina Åhrén
    Martin Welker
    Edward R. B. Moore
    Liselott Svensson Stadler
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 57 - 68
  • [43] Method for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries
    Hu, Bi-Huang
    Jones, Marsha Ritter
    Messersmith, Phillip B.
    ANALYTICAL CHEMISTRY, 2007, 79 (19) : 7275 - 7285
  • [44] A Combination of MALDI-TOF MS Proteomics and Species-Unique Biomarkers' Discovery for Rapid Screening of Brucellosis
    Hamidi, Hamideh
    Nejad, Ramin Bagheri
    Es-haghi, Ali
    Ghassempour, Alireza
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2022, 33 (08) : 1530 - 1540
  • [45] A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases
    Karine Guitot
    Thierry Drujon
    Fabienne Burlina
    Sandrine Sagan
    Sandra Beaupierre
    Olivier Pamlard
    Robert H. Dodd
    Catherine Guillou
    Gérard Bolbach
    Emmanuelle Sachon
    Dominique Guianvarc’h
    Analytical and Bioanalytical Chemistry, 2017, 409 : 3767 - 3777
  • [46] Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry
    Unger, Melissa S.
    Blank, Martina
    Enzlein, Thomas
    Hopf, Carsten
    NATURE PROTOCOLS, 2021, 16 (12) : 5533 - 5558
  • [47] A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases
    Guitot, Karine
    Drujon, Thierry
    Burlina, Fabienne
    Sagan, Sandrine
    Beaupierre, Sandra
    Pamlard, Olivier
    Dodd, Robert H.
    Guillou, Catherine
    Bolbach, Gerard
    Sachon, Emmanuelle
    Guianvarc'h, Dominique
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2017, 409 (15) : 3767 - 3777
  • [48] Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry
    Melissa S. Unger
    Martina Blank
    Thomas Enzlein
    Carsten Hopf
    Nature Protocols, 2021, 16 : 5533 - 5558
  • [49] Rapid screening of Alternaria mycotoxins using MALDI-TOF mass spectrometry
    Sivagnanam, Kumaran
    Komatsu, Emy
    Rampitsch, Christoph
    Perreault, Helene
    Grafenhan, Tom
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2017, 97 (01) : 357 - 361
  • [50] Rapid Screening of Ergot Alkaloids in Sclerotia by MALDI-TOF Mass Spectrometry
    Sivagnanam, Kumaran
    Komatsu, Emy
    Patrick, Susan
    Rampitsch, Christoph
    Perreault, Helene
    Grafenhan, Tom
    JOURNAL OF AOAC INTERNATIONAL, 2016, 99 (04) : 895 - 898